AstraZenca
AstraZeneca’s Covid-19 Booster and Antibody Cocktail Retains Neutralizing Ability against Omicron
2021-12-27
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
LATEST
Study Highlights Improved Outcomes in Mandibular Reconstruction Using Patient-Specific Implants
2026-01-25
Study Explores Role of Peer Recovery Coaches in Substance Use Recovery Programs Across the United States
2026-01-25
Advancements in Genomic Classification of Corynebacterium diphtheriae Strains Address Microbial Resistance Challenges
2026-01-25



